Fang Tan

Title: Fang Tan: Innovator in Microbial Research

Introduction

Fang Tan is a prominent inventor based in Chongqing, China. He has made significant contributions to the field of microbial research, particularly in relation to inflammatory colon cancer. His innovative work has the potential to impact cancer treatment and prevention.

Latest Patents

Fang Tan holds a patent for "Lacticaseibacillus rhamnosus AFY01 and application of product prepared from lacticaseibacillus rhamnosus AFY01 in inflammatory colon cancer." This patent, identified by the preservation number CGMCC No. 27362, details the effectiveness of AFY01 in alleviating weight loss, intestinal inflammation, and edema induced by colon cancer in mice. The findings suggest that AFY01 can reduce the colon coefficient, visceral index, and incidence of intestinal tumors, while also promoting apoptosis of intestinal tumor cells. This research expands bacterial resources and provides technical support for the prevention and treatment of colorectal cancer.

Career Highlights

Fang Tan is affiliated with Chongqing University of Education, where he continues to advance his research in microbial applications. His work is characterized by a commitment to improving health outcomes through innovative scientific approaches.

Collaborations

Fang Tan collaborates with notable colleagues, including Xin Zhao and Xin Ma, who contribute to his research endeavors. Their combined expertise enhances the impact of their work in the field of microbial research.

Conclusion

Fang Tan's contributions to microbial research, particularly in the context of inflammatory colon cancer, highlight his role as an innovator in the field. His patent for Lacticaseibacillus rhamnosus AFY01 represents a significant advancement in cancer treatment strategies.